tailieunhanh - Down-regulation of NF kappa B activation is an effective therapeutic modality in acquired platinum-resistant bladder cancer

No previous study has addressed the efficacy of NF-κB blockade when bladder tumors develop acquired resistance toward CDDP-treatments. We investigated the changes in NF-κB activation and therapeutic impact of NF-κB blockade by the novel NF-κB inhibitor dehydroxymethyl derivative of epoxyquinomicin (DHMEQ) in CDDP-resistant bladder cancer cells. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN